Sunday, 15/11/2020 14:43 WIB
–
WHO building in New York, USA.
–
Jakarta, law-justice.co – The World Health Organization (WHO) issued an emergency use permit for the polio nOPV2 vaccine belonging to the Indonesian State-Owned Enterprise (BUMN), PT Bio Farma (Persero). The emergency use permit was issued to tackle the increasing cases of polio in a number of African and East Mediterranean countries.
“WHO today includes the nOPV2 vaccine (Bio Farma, Indonesia) in the list of emergency use in order to deal with the high number of positive cases of polio in a number of African and East Mediterranean countries,” said the official statement from WHO on Friday (11/13/2020). “The western Pacific region and Southeast Asia are also affected by this outbreak.”
This is the first time WHO has included a vaccine in the emergency use list (EUL). This also opens the possibility for WHO to include a corona virus vaccine (COVID-19) in the EUL.
“The world has made tremendous progress in eradicating polio, reducing polio cases by 99.9 percent in the last 30 years,” continued the WHO. “But the final steps to end this disease are proving to be the most difficult, especially with vaccine-derived poliovirus (cVDPVs) continuing to circulate.”
For information, the nOPV2 vaccine is a new type of anti-polio virus (cVDPVs) developed by a global collaborative network of institutions and experts from various countries, the Global Initiative to Eradicate Polio (GPEI). cVDPVs themselves are rare and will only occur if the attenuated strains of polio virus contained in the oral polio vaccine (OPV) circulate among populations that are not immunized for a long time.
“If the number of children who receive immunization against polio is not enough, then the weakened virus can move between individuals and over time genetically return to forms that can cause paralysis,” explained WHO. “cVDPVs type 2 are currently the most common form of vaccine-derived virus.”
The EUL procedure is called WHO will assess the suitability of unlicensed health products during public health emergencies, such as polio and COVID-19. That way, medicines and vaccines can become available more quickly to deal with emergencies.
WHO introduced the EUL application procedure when Ebola broke out in West Africa in 2014-2016. There are at least three main stages that a vaccine candidate must go through to obtain an emergency use permit, namely the preparation phase, the emergency phase, and the phase after entering the emergency use permit list. .
–
()
– .
/nginx/o/2020/11/13/13473277t1h3272.jpg?resize=150%2C150&ssl=1)
